007390 — NatureCell Co Share Price
Last trade - 00:00- KR₩2tn
- KR₩2tn
- KR₩32bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 27.64 | ||
| Price to Tang. Book | 28.75 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 55.23 | ||
| EV to EBITDA | 729.33 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.85% | ||
| Return on Equity | 1.95% | ||
| Operating Margin | 1.78% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 16,719.8 | 22,204.01 | 21,252.02 | 19,350.89 | 32,333.91 | n/a | n/a | 6.98% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
NatureCell Co Ltd is a Korea-based company principally engaged in the stem cell business. The Company operates its business through three segments. The Stem Cell Business segment is engaged in the development of stem cell therapeutics, the manufacture of stem cell culture media, the development and sale of stem cell culture cosmetics, and the provision of blood cell storage services, among others. The Food Business segment is engaged in the manufacture and sale of fruit beverages including tomato juice, peach juice and others, canned beverages such as sikhye, fruit concentrates and others, as well as fermentation and health functional foods. The Hygiene Business segment is engaged in the manufacture and sale of health hygiene products such as masks, disinfectants, wipes, and others.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 6th, 1971
- Public Since
- November 30th, 1992
- No. of Shareholders
- 47,384
- No. of Employees
- 116
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 64,357,156
- Address
- 21, Gisangongdan 1-gil, Gisan-myeon, SEOUL, 07238
- Web
- https://www.naturecell.co.kr/
- Phone
- +82 25454137
- Auditors
- Samil Accounting Corp.
Upcoming Events for 007390
Similar to 007390
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
AHN-GOOK PHARMACEUTICAL Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 22:12 UTC, shares in NatureCell Co are trading at KR₩27,750. This share price information is delayed by 15 minutes.
Shares in NatureCell Co last closed at KR₩27,750 and the price had moved by +221.93% over the past 365 days. In terms of relative price strength the NatureCell Co share price has outperformed the FTSE Developed Asia Pacific Index by +225.6% over the past year.
There is no consensus recommendation for this security.
Find out moreNatureCell Co does not currently pay a dividend.
NatureCell Co does not currently pay a dividend.
NatureCell Co does not currently pay a dividend.
To buy shares in NatureCell Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩27,750, shares in NatureCell Co had a market capitalisation of KR₩2tn.
Here are the trading details for NatureCell Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 007390
Based on an overall assessment of its quality, value and momentum NatureCell Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NatureCell Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +95.51%.
As of the last closing price of KR₩27,750, shares in NatureCell Co were trading +62.33% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The NatureCell Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩27,750.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
NatureCell Co's management team is headed by:
- Jeong Chan Rah - CEO
- Nam Su Kim - OTH
- Yong Geun Choi - OTH